News

AcariaHealth Honored with 2023 Specialty Pharmacy Patient Choice Award

Date: 05/01/2023


AcariaHealth is pleased to announce that it has been recognized as the winner of the annual Specialty Pharmacy Patient Choice Award. The Managed Markets Insights and Technology (MMIT) Patient Choice Award honors a specialty pharmacy’s best-in-class customer satisfaction and overall patient care. AcariaHealth was recognized in the Payer/PBM Specialty Pharmacy category.

“AcariaHealth is extremely proud to be recognized as a 2023 Specialty Pharmacy Patient Choice Award winner,” said Steve Jensen, President of AcariaHealth. “Our dedication to delivering the greatest level of care to our patients and their families sets us apart as an industry leader. To be recognized on the national stage by the patients we serve is truly a humbling honor. Congratulations to our specialty pharmacy team members for their hard work and commitment to improving the health of our communities, one person at a time.”

 

The 2023 finalists and winners earned their rankings based on their average Net Promoter Score, an index that measures patients’ willingness to recommend their pharmacy to others, as assessed by quarterly Zitter Health Insights (ZHI) Patient Satisfaction Surveys conducted during the 2022 calendar year. The four surveys, formulated by an external awards committee comprised of individuals representing pharmaceutical manufacturers, payers, trade organizations, consultants, and equity research firms, measure numerous aspects of patient satisfaction and a pharmacy’s exemplary commitment to patients.

The MMIT ZHI quarterly surveys bring transparency to the pharmacy/patient relationship by leveraging innovative technology and data powered by human validation. Each year, responses are analyzed from more than 10,000 specialty pharmacy patients across four categories: Payer/PBM, Hospital and Health Systems, Independent, and Retail. The results of this objective assessment provide valuable unbiased patient feedback that allows participants to evaluate their performance against previous quarters and competitor scores in the areas of patient perception, access, and adherence.

 

Related Content